352 related articles for article (PubMed ID: 37915578)
1. Landscape of tumor and immune system cells-derived exosomes in lung cancer: mediators of antitumor immunity regulation.
Castillo-Peña A; Molina-Pinelo S
Front Immunol; 2023; 14():1279495. PubMed ID: 37915578
[TBL] [Abstract][Full Text] [Related]
2. Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts.
Khan NA; Asim M; Biswas KH; Alansari AN; Saman H; Sarwar MZ; Osmonaliev K; Uddin S
J Exp Clin Cancer Res; 2023 Aug; 42(1):221. PubMed ID: 37641132
[TBL] [Abstract][Full Text] [Related]
3. The biological functions and clinical applications of exosomes in lung cancer.
Chen R; Xu X; Qian Z; Zhang C; Niu Y; Wang Z; Sun J; Zhang X; Yu Y
Cell Mol Life Sci; 2019 Dec; 76(23):4613-4633. PubMed ID: 31352532
[TBL] [Abstract][Full Text] [Related]
4. Formation, contents, functions of exosomes and their potential in lung cancer diagnostics and therapeutics.
Xia Z; Qing B; Wang W; Gu L; Chen H; Yuan Y
Thorac Cancer; 2021 Dec; 12(23):3088-3100. PubMed ID: 34734680
[TBL] [Abstract][Full Text] [Related]
5. Exosomes carrying immune checkpoints, a promising therapeutic approach in cancer treatment.
Rasihashemi SZ; Sahrai H; Rezazadeh-Gavgani E; Yazdani Y; Khalaji A; Lotfinejad P
Med Oncol; 2022 Sep; 39(12):183. PubMed ID: 36071295
[TBL] [Abstract][Full Text] [Related]
6. The effect of tumor-derived exosomes on immune regulation and cancer immunotherapy.
Whiteside TL
Future Oncol; 2017 Dec; 13(28):2583-2592. PubMed ID: 29198150
[TBL] [Abstract][Full Text] [Related]
7. Tumor-Derived Exosomes in Immunosuppression and Immunotherapy.
Olejarz W; Dominiak A; Żołnierzak A; Kubiak-Tomaszewska G; Lorenc T
J Immunol Res; 2020; 2020():6272498. PubMed ID: 32537468
[TBL] [Abstract][Full Text] [Related]
8. Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response.
Wu J; Zeng D; Zhi S; Ye Z; Qiu W; Huang N; Sun L; Wang C; Wu Z; Bin J; Liao Y; Shi M; Liao W
J Transl Med; 2021 Sep; 19(1):381. PubMed ID: 34496872
[TBL] [Abstract][Full Text] [Related]
9. Immune suppressed tumor microenvironment by exosomes derived from gastric cancer cells via modulating immune functions.
Liu J; Wu S; Zheng X; Zheng P; Fu Y; Wu C; Lu B; Ju J; Jiang J
Sci Rep; 2020 Sep; 10(1):14749. PubMed ID: 32901082
[TBL] [Abstract][Full Text] [Related]
10. Exosome mediated communication within the tumor microenvironment.
Milane L; Singh A; Mattheolabakis G; Suresh M; Amiji MM
J Control Release; 2015 Dec; 219():278-294. PubMed ID: 26143224
[TBL] [Abstract][Full Text] [Related]
11. Emerging role of exosomes in cancer progression and tumor microenvironment remodeling.
Paskeh MDA; Entezari M; Mirzaei S; Zabolian A; Saleki H; Naghdi MJ; Sabet S; Khoshbakht MA; Hashemi M; Hushmandi K; Sethi G; Zarrabi A; Kumar AP; Tan SC; Papadakis M; Alexiou A; Islam MA; Mostafavi E; Ashrafizadeh M
J Hematol Oncol; 2022 Jun; 15(1):83. PubMed ID: 35765040
[TBL] [Abstract][Full Text] [Related]
12. Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression.
Liang M; Chen X; Wang L; Qin L; Wang H; Sun Z; Zhao W; Geng B
J Exp Clin Cancer Res; 2020 Aug; 39(1):176. PubMed ID: 32867817
[TBL] [Abstract][Full Text] [Related]
13. New insights into exosome mediated tumor-immune escape: Clinical perspectives and therapeutic strategies.
Pathania AS; Prathipati P; Challagundla KB
Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188624. PubMed ID: 34487817
[TBL] [Abstract][Full Text] [Related]
14. A Clinician's Guide to Cancer-Derived Exosomes: Immune Interactions and Therapeutic Implications.
Knox MC; Ni J; Bece A; Bucci J; Chin Y; Graham PH; Li Y
Front Immunol; 2020; 11():1612. PubMed ID: 32793238
[TBL] [Abstract][Full Text] [Related]
15. Exosomes Function in Tumor Immune Microenvironment.
Huang Y; Liu K; Li Q; Yao Y; Wang Y
Adv Exp Med Biol; 2018; 1056():109-122. PubMed ID: 29754177
[TBL] [Abstract][Full Text] [Related]
16. Role of exosomes in lung cancer: A comprehensive insight from immunomodulation to theragnostic applications.
Khan FH; Reza MJ; Shao YF; Perwez A; Zahra H; Dowlati A; Abbas A
Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188776. PubMed ID: 35961620
[TBL] [Abstract][Full Text] [Related]
17. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
18. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT.
Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J
Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived exosomes: Key players in non-small cell lung cancer metastasis and their implication for targeted therapy.
Rizwan MN; Ma Y; Nenkov M; Jin L; Schröder DC; Westermann M; Gaßler N; Chen Y
Mol Carcinog; 2022 Mar; 61(3):269-280. PubMed ID: 34897815
[TBL] [Abstract][Full Text] [Related]
20. Function and therapeutic development of exosomes for cancer therapy.
Kim SB
Arch Pharm Res; 2022 May; 45(5):295-308. PubMed ID: 35604532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
